CENGILD | CENGILD MEDICAL BERHAD

9 9
0.305 (1.67%)

T-O (am): 0.305 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score

CENGILD | CENGILD MEDICAL BERHAD

iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS
Adj.
[M]
NP [M]
(adj)
NPM
(adj)
EPS
(adj)
E. QoQ
(adj)
E. YoY
(adj)
TTM EPS
(adj)
27 Feb 24 Q2 Dec 23 2 30 Jun 24 16.05 4.00 2.92 18.2% 0.37 0.35 8.8% 16.5% 18.8% 30.0%
24 Nov 23 Q1 Sep 23 1 30 Jun 24 17.60 4.74 3.60 20.4% 0.00 0.43 11.6% 0.1% 60.8% 0.5%
24 Aug 23 Q4 Jun 23 4 30 Jun 23 15.77 2.67 2.24 14.2% 0.37 0.27 10.8% 8.0% 31.3% 41.3%
30 May 23 Q3 Mar 23 3 30 Jun 23 17.67 4.40 3.26 18.4% 0.00 0.40 8.1% 11.9% 22.1% 84.0%
28 Feb 23 Q2 Dec 22 2 30 Jun 23 19.22 5.42 4.18 21.7% 0.37 0.51 9.1% 14.2% 15.5% 71.5%
25 Nov 22 Q1 Sep 22 1 30 Jun 23 17.62 4.88 3.62 20.5% 0.00 0.44 2.8% 5.1%
25 Aug 22 Q4 Jun 22 4 30 Jun 22 17.14 3.37 3.81 22.2% 0.37 0.49 8.5% 115.3%
26 May 22 Q3 Mar 22 3 30 Jun 22 15.79 3.13 1.77 11.2% 0.00 0.30 6.2% 27.3%
30 Mar 22 Q2 Dec 21 2 30 Jun 22 16.83 3.34 2.44 14.5% 0.00 0.41

Historical Dividends

Financial Ratios

EPS 1.44 sen
Trailing PE (Sector Median: 25.4) 21.1
PEG 21.1
Altman Z 1.8
Beaver 0.298
Current Ratio 7.98
Debt-Equity (DE) Ratio 0.25
FCF Yield 2.67 %
Revenue QoQ -8.8 %
Revenue YoY -16.48%
Profit QoQ -18.78 %
Profit YoY -30.04 %
Profit Margin (Sector Median: 10.1) 17.91 %
ROE (ROIC: 10.95) 10.95 %
Dividend Per Share (DPS) 0.74 sen
Dividend Yield (DY) 2.43 %

Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 25.4)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 10.1)
ROE (ROIC: 10.95)
Altman Z

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.13
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 2.92
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0
Expected Revenue (M) 0
Expected Growth (%) 0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


DR CHONG SU-LIN reduced 100000.0 units announced on 09 Jan 2023 at ~RM0.49

Summary


Market Cap: 254 M.

Number of Shares: 832 M.

Adjusted Float: 60.2%.

Stock highly correlated with

ARREIT (95%)

NOVA (95%)

HWGB (94%)

TONGHER (94%)

Cengild Medical Berhad is an investment holding company and through its subsidiaries, the company is a healthcare provider specialising in the diagnosis and treatment of gastrointestinal and liver diseases and obesity. The company also provides consulting services and medical management services which comprise nursing services and clinical support services. Cengil Medical Berhad was incorporated in 2021 and is based in Kuala Lumpur, Malaysia.

Sectors: Healthcare, Health Care Providers, Penny Stocks

Code: 0243

Website: https://www.cengild.com/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 2-Oct-2023

Shareholder % Value (M)
Dato' Dr. Tan Huck Joo 16.18% 41.1
Anne Marie Loh Foong Han 9.64% 24.49
Emeritus Professor Dato' Dr Goh Khean Lee 7.23% 18.37
Dr. Mohamed Akhtar Bin Mohamed Ditali Qureshi 6.76% 17.17
Tan Kar Tek 4.83% 12.27
Ramesh A/L K Gurunathan 4.73% 12.02
Ong Siew Kuen 3.87% 9.83
Medic Quest Sdn Bhd 3.48% 8.84
Tony Tan Choon Keat 3.28% 8.33
Transmetro Sdn Bhd 2.81% 7.14
Tan Soon Wah 1.59% 4.04
Tang Vee Mun 1.57% 3.99
Koon Poh Keong 1.56% 3.96
Lai Kwong Choy 1.55% 3.94
Amanah Saham Sarawak 1.32% 3.35
Great Eastern Group 1.22% 3.1
Amir Azlan Zain 0.67% 1.7
Tan Lim Tneah Kooi 0.47% 1.19
Wang Phaik Mear 0.46% 1.17
Kuok Su Sim 0.42% 1.07
Yong Wan Yee 0.41% 1.04
Pmb Shariah Equity Fund 0.34% 0.86
Kang Hoo Chong 0.32% 0.81
Foong Siew Ee 0.31% 0.79
Lim Ban Hock 0.27% 0.69
AIA Group 0.26% 0.66
Wong Phooi Kheong 0.26% 0.66
Barclays Capital Securities Ltd 0.25% 0.64
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.